TRAW · Traws Pharma, Inc. · Webcasts, Transcripts & Audio
$0.57
+0.02 (+4.25%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on current projections, the Company believes that it does not have sufficient cash and cash equivalents to support its operations for more than one year following the date that these financial statements are issued. As a result of these conditions, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.66M
Shares
15.37M
Volume · Oct 2
69.63K
Avg daily vol (3M)
570.37K
Traws Pharma, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Traws Pharma, Inc. (TRAW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲90%
$57,000
−$6.43M
'20 Q4
21-03-11
▲7.7%
$56,000
−$4.71M
'21 Q1
21-05-17
▲1.8%
$57,000
−$4.23M
'21 Q2
21-08-12
▼13.6%
$57,000
−$3.45M
'21 Q3
21-11-12
▼1.8%
$56,000
−$3.76M
'21 Q4
22-03-17
▲0%
$56,000
−$4.12M
'22 Q1
22-05-11
▲0%
$57,000
−$4.02M
'22 Q2
22-08-11
▲0%
$57,000
−$5.40M
'22 Q3
22-11-14
▲0%
$56,000
−$5.42M
'22 Q4
23-03-16
▲0%
$56,000
−$5.78M
'23 Q1
23-05-15
▲0%
$57,000
−$4.25M
'23 Q2
23-08-10
▲0%
$57,000
−$4.74M
'23 Q3
23-11-14
▲0%
$57,000
−$123.14M
'24 Q2
24-08-15
▲0%
$56,000
−$29.92M
'24 Q4
25-03-31
LATEST
▲4694.7%
$2.73M
−$915,000
'25 Q2
25-08-14
Earnings call
FY26 · Q1
2026-04-15
Traws Pharma, Inc. (TRAW) Q1 2026 Earnings Call
Diluted EPS
$-0.53
▼ 125.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Traws Pharma, Inc. (TRAW) Q2 2025 Earnings Call Transcript
Positive tone
COVID program (ratutrelvir)
Influenza/bird flu program (tivoxavir marboxil)
Public health positioning
Revenue
$2.73M
▲ 4694.7% YoY Diluted EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Traws Pharma, Inc. (TRAW) Q4 2024 Earnings Call
Revenue
$56,000*
▲ 0% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2024-08-15
Traws Pharma, Inc. (TRAW) Q2 2024 Earnings Call
Revenue
$57,000
▲ 0% YoY Diluted EPS
$-20.52
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-11-14
Traws Pharma, Inc. (TRAW) Q3 2023 Earnings Call
Revenue
$57,000
▲ 0% YoY Diluted EPS
$-5.64
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Traws Pharma, Inc. (TRAW) Q2 2023 Earnings Call
Revenue
$57,000
▲ 0% YoY Diluted EPS
$-5.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Traws Pharma, Inc. (TRAW) Q1 2023 Earnings Call
Revenue
$56,000
▲ 0% YoY Diluted EPS
$-7.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Traws Pharma, Inc. (TRAW) Q4 2022 Earnings Call
Revenue
$56,000*
▲ 0% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Traws Pharma, Inc. (TRAW) Q3 2022 Earnings Call
Revenue
$57,000
▲ 0% YoY Diluted EPS
$-6.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Traws Pharma, Inc. (TRAW) Q2 2022 Earnings Call
Revenue
$57,000
▲ 0% YoY Diluted EPS
$-4.75
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Traws Pharma, Inc. (TRAW) Q1 2022 Earnings Call
Revenue
$56,000
▲ 0% YoY Diluted EPS
$-5.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-17
Traws Pharma, Inc. (TRAW) Q4 2021 Earnings Call
Revenue
$56,000*
▼ 1.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Traws Pharma, Inc. (TRAW) Q3 2021 Earnings Call
Revenue
$57,000
▼ 13.6% YoY Diluted EPS
$-5.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Traws Pharma, Inc. (TRAW) Q2 2021 Earnings Call
Revenue
$57,000
▲ 1.8% YoY Diluted EPS
$-6.75
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Traws Pharma, Inc. (TRAW) Q1 2021 Earnings Call
Revenue
$56,000
▲ 7.7% YoY Diluted EPS
$-8.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
Traws Pharma, Inc. (TRAW) Q4 2020 Earnings Call
Revenue
$57,000*
▲ 90% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-12
Traws Pharma, Inc. (TRAW) Q3 2020 Earnings Call
Revenue
$66,000
▲ 4.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-12
Traws Pharma, Inc. (TRAW) Q2 2020 Earnings Call
Revenue
$56,000
▼ 97.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Traws Pharma, Inc. (TRAW) Q1 2020 Earnings Call
Revenue
$52,000
▼ 23.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-24
Traws Pharma, Inc. (TRAW) Q4 2019 Earnings Call
Revenue
$30,000*
▼ 49.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–20 of 20 webcasts